| 1 | negative regulation of nitric-oxide synthase activity (GO:0051001) | 8.75144200 |
| 2 | negative regulation of protein localization to cell surface (GO:2000009) | 7.32581464 |
| 3 | negative regulation of cardiac muscle tissue growth (GO:0055022) | 6.81928706 |
| 4 | negative regulation of heart growth (GO:0061117) | 6.81928706 |
| 5 | regulation of sarcomere organization (GO:0060297) | 6.49059342 |
| 6 | regulation of skeletal muscle contraction (GO:0014819) | 6.19207674 |
| 7 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 6.14656071 |
| 8 | plasma membrane repair (GO:0001778) | 6.01328465 |
| 9 | negative regulation of cardiac muscle tissue development (GO:0055026) | 5.90023857 |
| 10 | negative regulation of organelle assembly (GO:1902116) | 5.66967760 |
| 11 | membrane raft organization (GO:0031579) | 5.62005502 |
| 12 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 5.36561435 |
| 13 | negative regulation of muscle hypertrophy (GO:0014741) | 5.32530251 |
| 14 | ribonucleoprotein complex disassembly (GO:0032988) | 5.29390317 |
| 15 | positive regulation of respiratory burst (GO:0060267) | 5.27433414 |
| 16 | negative regulation of monooxygenase activity (GO:0032769) | 5.25539064 |
| 17 | DNA deamination (GO:0045006) | 4.65457018 |
| 18 | membrane assembly (GO:0071709) | 4.50599688 |
| 19 | regulation of cardiac muscle cell differentiation (GO:2000725) | 4.47027575 |
| 20 | regulation of action potential (GO:0098900) | 4.32040036 |
| 21 | organelle disassembly (GO:1903008) | 4.28571478 |
| 22 | lens fiber cell differentiation (GO:0070306) | 4.27407174 |
| 23 | positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic proc | 4.23946159 |
| 24 | regulation of respiratory burst (GO:0060263) | 4.22175938 |
| 25 | negative regulation of cardiac muscle hypertrophy (GO:0010614) | 4.03912623 |
| 26 | positive regulation of glomerulus development (GO:0090193) | 4.00409129 |
| 27 | regulation of glomerulus development (GO:0090192) | 3.96618649 |
| 28 | response to pheromone (GO:0019236) | 3.76917602 |
| 29 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 3.73122789 |
| 30 | response to lipoprotein particle (GO:0055094) | 3.72510130 |
| 31 | somite development (GO:0061053) | 3.70003476 |
| 32 | striated muscle atrophy (GO:0014891) | 3.66725445 |
| 33 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 3.64763001 |
| 34 | regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis (GO:0003339 | 3.62458834 |
| 35 | cellular response to ATP (GO:0071318) | 3.55558956 |
| 36 | protein heterotetramerization (GO:0051290) | 3.50618691 |
| 37 | pericardium development (GO:0060039) | 3.50473481 |
| 38 | regulation of alkaline phosphatase activity (GO:0010692) | 3.50444525 |
| 39 | positive regulation of cardiac muscle cell differentiation (GO:2000727) | 3.50171687 |
| 40 | synapsis (GO:0007129) | 3.49362861 |
| 41 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c (GO | 3.42807376 |
| 42 | negative regulation of organ growth (GO:0046621) | 3.39518462 |
| 43 | NADH dehydrogenase complex assembly (GO:0010257) | 3.39254623 |
| 44 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 3.39254623 |
| 45 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 3.39254623 |
| 46 | muscle atrophy (GO:0014889) | 3.33433005 |
| 47 | regulation of membrane repolarization (GO:0060306) | 3.30402177 |
| 48 | water-soluble vitamin biosynthetic process (GO:0042364) | 3.17210809 |
| 49 | muscle cell cellular homeostasis (GO:0046716) | 3.15020097 |
| 50 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 3.14644409 |
| 51 | protein K6-linked ubiquitination (GO:0085020) | 3.14541188 |
| 52 | negative regulation of cell size (GO:0045792) | 3.09077899 |
| 53 | negative regulation of oxidoreductase activity (GO:0051354) | 3.08692788 |
| 54 | lateral sprouting from an epithelium (GO:0060601) | 3.05927545 |
| 55 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 3.05016877 |
| 56 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 3.05016877 |
| 57 | protein complex biogenesis (GO:0070271) | 3.02988264 |
| 58 | cytoplasmic microtubule organization (GO:0031122) | 3.02472256 |
| 59 | negative regulation of acute inflammatory response (GO:0002674) | 3.01581462 |
| 60 | organ formation (GO:0048645) | 3.00156141 |
| 61 | lymphangiogenesis (GO:0001946) | 2.98548708 |
| 62 | negative regulation of pathway-restricted SMAD protein phosphorylation (GO:0060394) | 2.88947768 |
| 63 | postreplication repair (GO:0006301) | 2.88771161 |
| 64 | detection of chemical stimulus involved in sensory perception of smell (GO:0050911) | 2.87845423 |
| 65 | muscle cell fate commitment (GO:0042693) | 2.85182668 |
| 66 | negative regulation of muscle tissue development (GO:1901862) | 2.84476377 |
| 67 | positive regulation of protein autophosphorylation (GO:0031954) | 2.84016923 |
| 68 | positive regulation of fatty acid oxidation (GO:0046321) | 2.83548764 |
| 69 | regulation of cell proliferation involved in kidney development (GO:1901722) | 2.81347872 |
| 70 | response to gravity (GO:0009629) | 2.78986218 |
| 71 | negative regulation of striated muscle tissue development (GO:0045843) | 2.78970752 |
| 72 | positive regulation of myotube differentiation (GO:0010831) | 2.78816432 |
| 73 | negative regulation of intracellular estrogen receptor signaling pathway (GO:0033147) | 2.77803397 |
| 74 | regulation of receptor binding (GO:1900120) | 2.75419275 |
| 75 | negative regulation of muscle organ development (GO:0048635) | 2.74126468 |
| 76 | regulation of potassium ion transmembrane transporter activity (GO:1901016) | 2.69423531 |
| 77 | ventricular cardiac muscle cell action potential (GO:0086005) | 2.69176466 |
| 78 | white fat cell differentiation (GO:0050872) | 2.67567195 |
| 79 | regulation of p38MAPK cascade (GO:1900744) | 2.67503078 |
| 80 | thyroid gland development (GO:0030878) | 2.67187174 |
| 81 | response to interferon-beta (GO:0035456) | 2.67024589 |
| 82 | positive regulation of branching involved in ureteric bud morphogenesis (GO:0090190) | 2.66338068 |
| 83 | pharyngeal system development (GO:0060037) | 2.65731955 |
| 84 | endoderm formation (GO:0001706) | 2.65125750 |
| 85 | intrinsic apoptotic signaling pathway in response to oxidative stress (GO:0008631) | 2.62672687 |
| 86 | mitochondrial respiratory chain complex assembly (GO:0033108) | 2.61340670 |
| 87 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.60891058 |
| 88 | muscle organ morphogenesis (GO:0048644) | 2.60093497 |
| 89 | regulation of collateral sprouting (GO:0048670) | 2.59779202 |
| 90 | positive regulation of microtubule polymerization (GO:0031116) | 2.59713362 |
| 91 | negative regulation of telomere maintenance (GO:0032205) | 2.58989104 |
| 92 | response to muscle activity (GO:0014850) | 2.58056066 |
| 93 | lung morphogenesis (GO:0060425) | 2.57940613 |
| 94 | positive regulation of extracellular matrix organization (GO:1903055) | 2.56473091 |
| 95 | chromosome organization involved in meiosis (GO:0070192) | 2.55637115 |
| 96 | regulation of hippo signaling (GO:0035330) | 2.54254209 |
| 97 | negative regulation of transcription regulatory region DNA binding (GO:2000678) | 2.54254038 |
| 98 | regulation of potassium ion transmembrane transport (GO:1901379) | 2.53480188 |
| 99 | cardiac muscle cell action potential involved in contraction (GO:0086002) | 2.51460825 |
| 100 | regulation of sequestering of triglyceride (GO:0010889) | 2.51045662 |
RPS14P4 
